Invirsa, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.invirsa.com
Clinical Trials
4
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (75.0%)Phase 1
1 (25.0%)Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy
Phase 2
Recruiting
- Conditions
- Non-center Involved Diabetic Macular EdemaNon-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic RetinopathyDiabetic RetinopathyCenter-involved Diabetic Macular EdemaCenter-involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Invirsa, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT06599684
- Locations
- 🇺🇸
MedTrials, Inc., Dallas, Texas, United States
Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
- First Posted Date
- 2024-04-17
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Invirsa, Inc.
- Target Recruit Count
- 109
- Registration Number
- NCT06370039
- Locations
- 🇺🇸
iuvo BioScience, Rush, New York, United States
Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis
Phase 2
Recruiting
- Conditions
- Acute Infectious Keratoconjunctivitis
- Interventions
- Drug: Vehicle
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Invirsa, Inc.
- Target Recruit Count
- 102
- Registration Number
- NCT05636228
- Locations
- 🇺🇸
Global Research Management, Glendale, California, United States
🇺🇸Foothill Eye Institute, Pasadena, California, United States
🇺🇸Shettle Eye Research, Largo, Florida, United States
Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Invirsa, Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT05586152
- Locations
- 🇺🇸
iuvo BioScience, Rush, New York, United States
News
No news found